Actualizaciones regulatorias
Novedades regulatorias de FDA, EMA, TGA y organismos globales
#Pravastatin ×
Actualizaciones regulatorias
27 sept 2026•1 min de lectura
FDA Approves ANDA077013 for Pravastatin Sodium Tablets by Pharmobedient
The FDA has approved application ANDA077013 for pravastatin sodium tablets (10‑80 mg) from sponsor Pharmobedient; all listed product numbers are marked discontinued.
Actualizaciones regulatorias
10 sept 2026•1 min de lectura
FDA Approves Amici Pharma’s Generic Pravastatin Sodium Tablets (ANDA 077491)
The FDA has approved the ANDA 077491 for Pravastatin Sodium tablets from Amici Pharma, covering strengths from 10 mg to 80 mg.